TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.620
-0.040 (-0.86%)
Sep 18, 2024, 4:00 PM EDT - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $135.42 million as of September 18, 2024. Its market cap has decreased by -15.10% in one year.
Market Cap
135.42M
Enterprise Value
141.70M
1-Year Change
-15.10%
Ranking
Category
Stock Price
$4.62
Market Cap Chart
Since December 18, 2020, TriSalus Life Sciences's market cap has decreased from $259.00M to $135.42M, a decrease of -47.71%. That is a compound annual growth rate of -15.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2024 | 136.60M | -38.58% |
| Dec 29, 2023 | 222.40M | -29.04% |
| Dec 30, 2022 | 313.40M | 1.52% |
| Dec 31, 2021 | 308.70M | 17.60% |
| Dec 31, 2020 | 262.50M | 1.35% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quantum-Si incorporated | 139.53M |
| aTyr Pharma | 139.47M |
| Vigil Neuroscience | 138.77M |
| Scilex Holding Company | 136.99M |
| InfuSystem Holdings | 136.85M |
| Prelude Therapeutics | 134.81M |
| Agenus | 134.39M |
| CervoMed | 133.22M |